ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2025
Clinical outcome of combined reverse total shoulder arthroplasty combined with pectoralis major transfer for rotator cuff arthropathy: a preliminary study.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeReverse total shoulder arthroplasty (RTSA) is promising treatment option for rotator cuff tear arthropathy (CTA), but internal rotation (IR) deficits can arise in patients with irreparable subscapularis tears. The present study reports (1) the early clinical outcomes of RTSA combined with pectoralis major (PM) transfer in patients with CTA and irreparable subscapularis tears and (2) compares these outcomes with those of RTSA without subscapularis repair, with a focus on addressing IR deficiencies and enhancing overall shoulder function.
methodsFrom November 2022 to May 2023, patients who underwent RTSA with PM transfer were reviewed. For comparison, patients who underwent RTSA without subscapularis repair between November 2019 and June 2022 were also included. The inclusion criteria consisted of CTA with severe subscapularis tears, classified as Lafosse grade ≥ 4, and poor subscapularis muscle quality, defined by Goutallier fatty infiltration grade ≥ 3. Clinical outcomes were assessed using the VAS, Constant, ASES, UCLA, and SANE, range of motion (ROM) and strength. Radiologic evaluations including radiography and MRI were performed. Patients with less than one year of follow-up or lost to final clinical assessment were excluded.
resultsAfter excluding one patient, 22 patients who underwent RTSA with PM transfer were included (mean age: 73.8 ± 6.0 years; follow-up: 16.7 ± 2.1 months). In the comparison group, 55 patients underwent RTSA without subscapularis repair (mean age: 73.6 ± 6.3 years; follow-up: 17.9 ± 3.2 months). For both groups, significant improvements were seen in VAS, Constant, ASES, UCLA, and SANE scores (P < .001), as well as ROM in forward elevation, abduction, and internal rotation at the back. Both groups showed comparable preoperative characteristics and similar postoperative improvements in clinical scores and ROM. However, the PM transfer group demonstrated more frequent reversal of subscapularis-specific tests and significantly greater strength in forward elevation, abduction, and IR at the side.
conclusionRTSA with PM transfer can significantly alleviate pain and improve shoulder function in patients with CTA and irreparable subscapularis tears. Compared to the group without subscapularis repair, the RTSA with PM transfer group demonstrated more frequent reversal of subscapularis-specific tests and significantly greater strength in forward elevation, abduction, and IR at the side. LEVEL OF EVIDENCE: IV; retrospective; case series.
Indexed as
Identifiers
40884712What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.